Pls the best way to treat glioma 10

Integrative medicine is recommended**.

At present, the more authoritative advanced technology is the sonodynamic ** of Chengdu Sonodynamic Tumor Research Institute, which has obvious control of glioma. I found some information, you can go and take a look,.

Advantages of sonodynamic** cancer tumors compared to chemoradiotherapy.

1.Radiotherapy and chemotherapy will cause great damage to normal human tissues in the process, and patients will have serious complications such as vomiting, hair loss, and pain, and various physical indicators will decline significantly.

The sonodynamic tumor is accurate and efficient, the ablation of cancer cells is obvious, the tumor is small, and the patient has no discomfort;

2.According to the average statistics of various types of cancer, the rate is at least 50%, and for serious tumors such as glioma and bladder cancer, the rate of timely surgery and radiotherapy and chemotherapy is 100%.

Sonodynamic ** tumors, first control the spread of tumors in the original lesions, and gradually kill cancer cells, through the case statistics of the past two years, except for advanced and severe cancer patients, the ** rate is controlled at the following.

3.Radiotherapy and chemotherapy are long, chemotherapy needs at least 4 times, and radiotherapy is more than 20 times, with an average time span of several weeks or months.

Sonodynamic ** tumors generally need 1 to 3 courses of treatment, each course of treatment only needs to be hospitalized for 3 to 5 days, and then recuperate at home for about a month, during which there is no need to carry out **, the same continuous killing of cancer cells, the effect is significant, the patient is more comfortable and free, and can significantly alleviate the complications caused by cancer.

Chengdu Institute of Acoustic Cancer is the only scientific research institution recognized by the competent authority for the diagnosis and treatment of acoustic tumors in the country, and the first acoustic tumor institution in China.

The so-called benign brain tumor refers to a tumor that grows in a certain part of the skull (mostly outside the cranial nerve tissue), has good tissue differentiation, grows slowly, and is pluripotent. Such as meningioma, pituitary adenoma, embryonic residual tumor and vascular tumor.

Malignant tumors in the epithelial tissue are called carcinomas, and malignant tumors in mesenchymal tissues are called sarcomas. It is customary to refer to all malignant tumors as cancers.

In 04, Mr. Luo Jiaying was diagnosed with advanced liver cancer, and his health is getting better and better under the guidance of the Hong Kong SAR Cancer Center, and he has been in good health for 14 years, and he also participated in HSCO on July 22 to improve anti-cancer knowledge, so cancer can be **.

That's a particularly good question. This is the current medical point of view, which is that it cannot be completely cured.

But from the perspective of traditional Chinese medicine, nutrition or acid-base balance theory, there are opportunities. And there are already relatively good cases.

If you have the opportunity, please consult Mr. Yuan Huaibin.

Hello, you can go to a regular hospital to hang up the TCM tumor clinic. Don't easily believe in the home remedies of the Jianghu doctor, so as not to delay the best time.

In addition, the combination of traditional Chinese and Western medicine** has a better effect on cancer, and surgery can be considered first if there are surgical conditions, and chemotherapy and radiotherapy can be combined with traditional Chinese medicine if there are no surgical conditions**. If the patient is older, whether the patient is suitable for chemoradiotherapy depends on the severity of the disease, the development of the disease, and the patient's physical condition.

There is now a laser interstitial hyperthermia (LITT) technology abroad, and many developed countries are doing this scientific research, especially in North America, which has been used for nearly ten years.

To put it simply, LITT is percutaneous minimally invasive surgery, in which a small incision is made on the scalp, about less than 4mm, and then a laser probe is used to reach into the brain, and the tumor is burned off with a laser, which is much faster than craniotomy, and a surgery is done in less than three hours.

LITT can treat glioma, epilepsy, radiation necrosis, etc., and the scope of application is quite wide, and it can be reused, which is very good, and the damage is much less than that of craniotomy. Moreover, if you don't want to do craniotomy for malignant brain tumors, you can also use Litt**, and foreign patients are now reluctant to have a craniotomy and do this minimally invasive surgery.

Another advantage of minimally invasive technology is that there are fewer complications, and there is no need to recuperate for so long, a professor in Canada named James Rutka said that his patients were discharged from the hospital the next day after LITT, so I think this technique is quite suitable for children.

1. Surgical excision. For glioma, surgical excision is the most commonly used method. It depends on the location of the tumor in the brain and whether the size of the tumor compresses the important innervated areas around it.

Craniotomy is a very difficult operation, so it is recommended to go to a specialist or public hospital to perform it, and it is necessary to closely observe the patient's reaction during the operation to determine the extent of resection.

2. Radiotherapy. Radiotherapy is mainly used in patients who cannot be surgically resected or who have undergone surgical resection and have adjuvant radiotherapy after surgery. For patients with glioma grade or above, postoperative radiotherapy is also required after surgical resection to reduce the chance.

Whether it is first-class radiotherapy or postoperative adjuvant radiotherapy, it is necessary to pay attention to the increased intracranial pressure that may be caused by radiotherapy, as well as long-term adverse reactions leading to unresponsiveness, dementia and other problems.

3. Chemotherapy. Temozolomide, a commonly used chemotherapy drug for glioma, can be given at the same time as radiotherapy**, or it can be used in conjunction with the chemotherapy drug after radiotherapy**.

In short, for glioma patients, what kind of best method to choose requires a comprehensive assessment of the patient's condition, physical condition, and economic situation. At the same time, it is necessary to pay strict attention to the adverse reactions that may occur in patients and give symptomatic reactions.

The latest method of glioma is still based on surgery, which resects the tumor to the greatest extent and protects nerve function as much as possible, which is the main method of glioma at present. At present, more progress focuses on the molecular typing of glioma, that is, if the stage of glioma is early, and the tumor has been completely resected, molecular typing is also a better type, and postoperative observation and close follow-up can be taken. In the case of high-grade glioma, that is, grade 3 and 4 with a relatively high degree of malignancy, postoperative adjuvant radiotherapy and chemotherapy are required.

Glioma is the most common primary central nervous system tumor (TCS) tumor with a specific tumor site that makes it difficult to implement effectively**. At present, the conventional plan for glioma is to surgically remove the tumor focus first, and cooperate with radiation**, chemical**, etc. after surgery. However, due to the infiltrative growth of glioma and the absence of a clear border between glioma and brain tissue, it is almost impossible to remove it completely.

In addition, due to the special location of the tumor, the risk of surgery is high, the trauma is large, and there are often sequelae of surgery.

The efficacy of routine radiation for glioma** is unsatisfactory, and acute toxicity during ** often occurs**, such as symptoms of radiation cerebral edema, headache, nausea and vomiting, and even radiation brain necrosis, psychiatric abnormalities and dementia. These often result in inability to continue**, or lead to an exacerbation of the patient's condition.

In 2014, the FDA-approved EDGE non-invasive tumor radiosurgery system is the most cutting-edge technology for glioma so far, with the characteristics of non-invasive, fast, accurate and thorough, which can effectively remove glioma, and the whole process does not require anesthesia, non-invasive, about 10 minutes each time, and up to 5 times. Patients do not need to be hospitalized.

The world's first EDGE system was officially put into operation in March 2014 at Henry Ford Hospital in the United States, and has so far handled more than 400 patients

Stage 1: Conventional radiotherapy (adjuvant chemotherapy and other measures if necessary) to localize the glioma;

Phase 2: According to the tumor focus after radiotherapy, EDGE non-invasive surgery is performed to remove the tumor.

Compared with conventional surgery and conventional chemotherapy, the EDGE non-invasive surgical removal system has the following advantages:

1.Non-invasive: no incisions are required and the patient does not need to undergo the great trauma of the surgery;

2.**Short time: about 10 minutes each time**, which does not affect the patient's quality of life;

3.**Less frequency: 1-5 times, once a day, no hospitalization**;

4.Efficient: It can remove up to 5 tumors at the same time, and the resection of tumors can reach 5-175px, which is suitable for almost all patients with solid tumors for lesion clearance;

5.Thorough: Tracking and locking the escaped tumor every 10 milliseconds and removing it, completely eliminating tumor cells;

6.High-intensity precision**: high-energy, millimeter-level precision eliminates tumor cells, and there is almost no damage to surrounding important organs and tissues;

7.Convenient: no anesthesia, no hospitalization;

8.There are almost no side effects: the patient does not have conventional surgery, radiotherapy.

In recent years, with the rapid development of biotechnology, immunity** is internationally recognized as the most promising new technology for the complete elimination of glioma**. That is, the treated autologous or allogeneic immune cells or immune molecules are infused to the patient, restore and enhance the immune monitoring and tumor killing function of glioma patients, effectively kill the residual tumor cells in the body after surgery and radiotherapy and chemotherapy, and achieve the purpose of glioma, prevention and metastasis and eventual glioma, which has the advantages of strong specificity and lightness.

The Center for Translational Neuroscience has established the first glioma stem cell bank in China to isolate, culture and store patients' own glioma stem cells, which not only solves the problem of scarcity of glioma antigens, but also provides an opportunity for those patients who have lost the opportunity to undergo glioma DC vaccine**. Figuratively speaking, the glioma stem cell bank not only stores cells, but also provides an opportunity to target glioma stem cell immunity, which is the hope of delaying.

Beijing 304 Hospital Neuro-Oncology** Center is a national tertiary hospital, so it is recommended that you go there.